Alan Charles Hartford MD PhD, FACR
Professor of Medicine (Radiation Oncology), Geisel School of Medicine at Dartmouth
Join to View Full Profile
275 Nichols RdFitchburg, MA 01420
Phone+1 978-343-5196
Dr. Hartford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1993 - 1997
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1992 - 1993
Harvard Medical SchoolClass of 1992
Certifications & Licensure
MA State Medical License 1996 - 2028
NH State Medical License 2004 - 2026
VT State Medical License 2007 - 2026
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013, 2015-2017
Clinical Trials
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer Start of enrollment: 2005 Jul 26
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
Publications & Presentations
PubMed
- 1 citationsBiopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.Krishnan R Patel, Paul L Nguyen, James A Proudfoot, Yang Liu, Alan Dal Pra
European Urology Oncology. 2026-04-01 - 17 citationsBladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.Douglas M Dahl, Joseph P Rodgers, William U Shipley, M Dror Michaelson, Chin-Lee Wu
Journal of Clinical Oncology. 2024-12-01 - 25 citationsExternal Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial.Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, Rikiya Yamashita, Jessica Keim-Malpass
European Urology Oncology. 2024-10-01
Authored Content
- ACR 2021 in BriefMay 2021
- Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
- Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
Press Mentions
Dr. Alan Hartford Selected to Be Inducted into IAOTP’s Hall of FameSeptember 6th, 2021- ACR 2021 in BriefMay 24th, 2021
Dartmouth Physician-Scientists Examine Efficacy of Radiation Therapy in 'Good-Risk' DCIS PatientsFebruary 12th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
